Virtual replicas of patients' hearts help doctors tackle irregular heartbeat
AP News • • health
Key Points:
- Researchers at Johns Hopkins University developed virtual digital twins of patients' diseased hearts to guide treatment for ventricular tachycardia, a difficult-to-treat arrhythmia causing about 300,000 U.S. deaths annually.
- In an FDA-approved trial involving 10 patients, the digital twin technology helped doctors identify precise ablation targets, resulting in eight patients free of arrhythmias after one year and better outcomes than the typical 60% success rate.
- The digital twins simulate how electrical waves move through the heart's ventricles, allowing doctors to virtually test ablation strategies before performing procedures, potentially reducing tissue damage and procedure time.
- This pioneering approach, detailed in the New England Journal of Medicine, represents a novel application of digital twin technology in medicine, with plans for larger studies and trials targeting other arrhythmias like atrial fibrillation.
- Experts view this as a significant advancement in personalized cardiac care, with potential broader applications in fields such as cancer treatment.
